Kevin N. Heller
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Jasper Therapeutics, Inc. (JSPR)
SEC 8-K
Current2021-09-24–present
-
Jasper Therapeutics, Inc. (JSPR)
Proxy statement
Start not stated–2022-05-17
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Jasper Therapeutics, Inc. (JSPR) | Executive Vice President, Research and Development | $454,395 | $617,987 |
| 2020 | Jasper Therapeutics, Inc. (JSPR) | Executive Vice President, Research and Development | $178,126 | $1,212,858 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.